Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg. Patients are also overwhelmingly ...

TUCSON, Ariz. (KGUN) — Diabetics have many options nowadays for their treatment plans. Afrezza is FDA-approved for adults with type 1 or type 2 diabetes as a fast-acting, mealtime insulin, but it ...

Cipla, a global name in inhalation therapies, has announced the launch of Afrezza, the world’s only rapid-acting inhaled insulin, in India. The drug is approved for adults with type 1 and type 2 ...

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

Please provide your email address to receive an email when new articles are posted on . Portal Pump is an investigational implantable device that delivers insulin directly to the peritoneal space. The ...